CD4 and breast cancer: In addition, prior studies have observed the expression level of MHC class II on the mammary tumor cells in tumor‐draining lymph nodes (TDLNs) was positively correlated with the progression of the metastasis in the LNs, by eliciting the CD4+ T cell tolerance and an immunosuppressive TME.44